Document is current
Any future updates will be listed below
-
Authors
Schiavetti, Irene
Villani, E.
Serafino, M.
Caputo, R.
Buzzonetti, L.
Vagge, A.
Nucci, P.
,
Bacci, Giacomo
Barresi, Contanza
Buzzonetti, Luca
Caputo, Roberto
Catti, Carlo
Cuccu, Alberto
Dello Strologo, Marika
Donati, Simone
Fontanel, Liviana
Frattolillo, Antonio
Gusson, Elena
Lepore, Domenico
Longo, Rosa
Magli, Adriano
Manitto, Maria Pia
Marchiori, Viola
Massa, Luigi
Menicacci, Cristina
Nucci, Paolo
Picardi, Ciro
Pignatto, Silvia
Pensiero, Stefano
Pini, Sara
Procoli, Ugo
Rombetto, Luca
Sabetti, Lelio
Salerni, Annabella
Scaramuzzi, Matteo
Schiavetti, Irene
Serafino, Massimiliano
Stoppani, Monica
Stramare, Giuliano
Vagge, Aldo
Valente, Paola
Vannucchi, Martino
Villani, Edoardo
Zampieri, Andrea
Zannin, Elisabetta
-
Funding
Funding for this research was provided by:
Università degli Studi di Genova
- License Information
-
More Information
Article History
Received: 30 December 2025
Revised: 5 March 2026
Accepted: 10 April 2026
First Online: 30 April 2026
Declarations
:
: PN: Thea, Zeiss, Hoya, Essilor Luxottica, Fondazione One-sight, Thea Sifi, Bausch&Lomb, Alfa Intes, Alcon, Doc, Santen, Eyerising, CooperVision IS: Roche, Biogen, Hoya, Hippocrates Research, D.M.G Italia, Eyepharma, and DreamsLab.The other authors have nothing to disclose.
